[1] Jemal A, Bray F, Center MM, et al.Global Cancer Statistics[J]. Cancer J Clin, 2011, 61(2): 69-90. [2] Sharma MC.An emerging biomarker and potential therapeutic target for aggressive cancers[J]. Int J Cancer, 2019, 144(9): 2074-2081. [3] Alauddin M, Salker MS, Umbach AT, et al.Annexin A7 Regulates Endometrial Receptivity[J]. Front Cell Dev Biol, 2020, 14(8): 770. [4] Hsu PI, Huang MS, Chen HC, et a1. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer[J]. J Surg Oncol, 2008, 97(7): 609-614. [5] Tan Z.Recent Advances in the Surgical Treatment of Advanced Gastric Cancer[J].A Review. Med Sci Monit, 2019,13(25): 3537-3541. [6] Lim LH, Pervaiz S.Annexin 1: the new face of an old molecule[J]. FASEB J, 2007, 21(4): 968-975. [7] Srivastava M, Bubendorf L, Raffeld M, et al.Prognostic impact of ANX7- GTPase in metastatic and HER2-negative breast cancer patients[J]. Clin Cancer Res, 2004, 10(7): 2344-2350. [8] Hung KS, Howng SL.Prognostic significance of annexin VII expression in glioblastomas multiforme in humans[J]. J Neurosurg, 2003, 99(5): 886892. [9] Sun MZ, Liu S, Tang J, et al.Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis[J]. Proteomics, 2009, 9(12): 3285-3302. [10] Yuan HF, Li Y, Tan BB, et al.Expression of annexin A7 and its clinical significance in gastric carcinoma[J]. Zhonghua Zhong Liu Za Zhi, 2016, 38(5): 346-350. [11] Ibrahim MM, Sun MZ, Huang Y, et al.Down-regulation of ANXA7 decreases metastatic potential of human hepatocellular carcinoma cells in vitro[J]. Biomed Pharmacother, 2013, 67(4): 285-291. [12] Ye W, Li Y, Fan L, et al.Effect of annexin A7 suppression on the apoptosis of gastric cancer cells[J]. Mol Cell Biochem, 2017, 429(1-2): 33-43. [13] Herce HD, Rajan M, Lattig-Tunnemann G, et al.A novel cell permeable DNA replication and repair marker[J]. Nucleus, 2014, 5(6): 590-600. [14] Lin L, Chen D, Xiang ZF, et al.Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3[J]. Cancer Biomark, 2017, 20(2): 217-224. [15] Li L, Mao X, Qin X,et al.Aspirin inhibits growth of ovarian cancer by upregulating caspase-3 and downregulating bcl-2[J]. Oncol Lett, 2019, 17(5): 4742. [16] Zhou Y, Cheng X, Wan Y, et al.MicroRNA-421 Inhibits Apoptosis by Downregulating Caspase-3 in Human Colorectal Cancer[J]. Cancer Manag Res, 2020, 21(12): 7579-7587. [17] Isobe N, Onodera H, Mori A, et al.Caspase-3 expression in human gastric carcinoma and its clinical significance[J]. Oncology, 2004, 66(3): 201-209. [18] Hu X, Zhang F, Luo D, et al.URI promotes gastric cancer cell motility, survival, and resistance to adriamycin in vitro[J]. Am J Cancer Res, 2016, 1(6): 1420-1430. |